U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895095) titled 'Oral Immunotherapy for Children With Peanut Allergy' on Sept. 28.

Brief Summary: This clinical trial aims to investigate if oral immunotherapy can help children with peanut allergy tolerate peanut.

Children aged 6 months to 4 years can take part in the trial.

Main question: What percentage of children can tolerate peanut after oral immunotherapy, compared with children who avoid peanut?

Children are assigned to these two groups by chance.

Children receiving oral immunotherapy will:

* Take a small, increasing amount of peanut daily for 1-1.5 years

* Attend clinic or online visits each time the dose is increased

* Record missed...